- Wednesday, April 3, 2024
7:00 AM – 8:00 AM ET
CE Symposium: Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology Pharmacists
7:00 AM – 8:00 AM ET
CE Symposium: Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology PharmacistsLocation: 120-121Co-Speaker: – University of California, Irvine
Co-Speaker: – University of Georgia College of Pharmacy
Co-Speaker: – Mayo Clinic
Shawn P. Griffin, PharmD, BCOP (he/him/his) – University of California, Irvine ### 1772980###Co-Speaker###Assistant Clinical Professor###University of California, Irvine###Co-Speaker: – University of California, Irvine
### he/him/his @@@ Amber Bradley Clemmons, PharmD, BCOP, FHOPA (she/her/hers) – University of Georgia College of Pharmacy ### 1177736###Co-Speaker###Clinical Professor###University of Georgia College of Pharmacy###Co-Speaker: – University of Georgia College of Pharmacy
### she/her/hers @@@ Kristen McCullough, PharmD, MS, BCPS, BCOP – Mayo Clinic ### 2127684###Co-Speaker###Hematology Clinical Pharmacy Specialist###Mayo Clinic###Co-Speaker: – Mayo Clinic
### 7:00 AM – 8:00 AM ET
CE Symposium: Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering Effective Therapy With Antibody Platforms
7:00 AM – 8:00 AM ET
CE Symposium: Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering Effective Therapy With Antibody PlatformsLocation: 124-125*Speaker: – Emory University School of Medicine
*Speaker: – University of Kansas Cancer Center
*Speaker: – Medical University of South Carolina
R. Donald Harvey, III, PharmD, BCOP, FCCP, FHOPA, FASCO – Emory University School of Medicine ### 1464551###*Speaker###Professor###Emory University School of Medicine###*Speaker: – Emory University School of Medicine
### @@@ Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA (she/her/hers) – University of Kansas Cancer Center ### 958456###*Speaker###Clinical Pharmacy Manager###University of Kansas Cancer Center###*Speaker: – University of Kansas Cancer Center
### she/her/hers @@@ James A. Davis, PharmD, BCOP – Medical University of South Carolina ### 1810470###*Speaker###Clinical Pharmacy Specialist – Malignant Hematology & Assistant Professor - MUSC College of Pharmacy###Medical University of South Carolina###*Speaker: – Medical University of South Carolina
### 7:00 AM – 8:00 AM ET
CE Symposium:Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operational Efficiency in Multiple Myeloma
7:00 AM – 8:00 AM ET
CE Symposium: Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operational Efficiency in Multiple MyelomaLocation: 122-123Co-Speaker: – University of Michigan Rogel Cancer Center
Co-Speaker:
Co-Speaker: – Moffitt Cancer Center
Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###Co-Speaker###Clinical Pharmacist###University of Michigan Rogel Cancer Center###Co-Speaker: – University of Michigan Rogel Cancer Center
### @@@ Joseph A. Kalis, PharmD, BCOP ### 2269369###Co-Speaker#########Co-Speaker:
### @@@ Rebecca Gonzalez, PharmD, BCOP (she/her/hers) – Moffitt Cancer Center ### 900574###Co-Speaker###Clinical Pharmacist in Blood and Marrow Transplant/Cellular Immunotherapy###Moffitt Cancer Center###Co-Speaker: – Moffitt Cancer Center
### she/her/hers8:00 AM – 12:00 PM ET
Pre-conference: From Data to Decisions: A Masterclass in Critical Appraisal of Cancer Research
8:00 AM – 12:00 PM ET
001 - Pre-conference: From Data to Decisions: A Masterclass in Critical Appraisal of Cancer ResearchLocation: Room 114-117Co-Speaker: – University of Michigan College of Pharmacy
Co-Speaker: – University of Michigan
Co-Speaker: – University of California San Diego
Bernard L. Marini, PharmD, BCOP (he/him/his) – University of Michigan College of Pharmacy ### 1254284###Co-Speaker###Clinical Pharmacist Specialist - Hematology###University of Michigan College of Pharmacy###Co-Speaker: – University of Michigan College of Pharmacy
### he/him/his @@@ Anthony J. Perissinotti, PharmD, BCOP – University of Michigan ### 1486423###Co-Speaker###Clinical Pharmacist Specialist - Hematology###University of Michigan###Co-Speaker: – University of Michigan
### @@@ Aaron Goodman, MD – University of California San Diego ### 2128381###Co-Speaker###Associate Professor of Medicine Division###University of California San Diego###Co-Speaker: – University of California San Diego
###
12:00 PM – 1:00 PM ET
Non-CE Symposium: How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?
12:00 PM – 1:00 PM ET
Non-CE Symposium: How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?Location: 122-123
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP ### 957901###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM ET
Non-CE Symposium: Brukinsa (zanubrutinib) for the treatment of adult patient with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
12:00 PM – 1:00 PM ET
Non-CE Symposium: Brukinsa (zanubrutinib) for the treatment of adult patient with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)Location: 124-125
Bhavesh Shah, RPh BCOP ### 957886###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM ET
Non-CE Symposium: Outcomes and Economic Impact of Treatment with CABLIVI®(caplacizumab-yhdp)
12:00 PM – 1:00 PM ET
Non-CE Symposium: Outcomes and Economic Impact of Treatment with CABLIVI®(caplacizumab-yhdp)Location: 120-121
Hillary Maitland, MD, MS ### 2251086###*Speaker#########*Speaker:
### @@@ Adam Gurry, MD, MS ### 2251087###*Speaker#########*Speaker:
### 1:15 PM – 2:30 PM ET
Diving into DEI: Increasing Inclusivity and Fostering Diversity in Clinical Trials
1:15 PM – 2:30 PM ET
BC1 - Diving into DEI: Increasing Inclusivity and Fostering Diversity in Clinical TrialsLocation: Ballroom B-CCo-Speaker: – UC Davis Health
Co-Speaker: – Stanford Health Care
Co-Speaker: – UCSF
Jennifer A. Murphy, PharmD, BCOP – UC Davis Health ### 2127665###Co-Speaker###Senior Pharmacist, Oncology & Investigational Drug Service###UC Davis Health###Co-Speaker: – UC Davis Health
### @@@ Elyse A. MacDonald, PharmD, BCPS, MS – Stanford Health Care ### 2127677###Co-Speaker###Director, Investigational Drug Service###Stanford Health Care###Co-Speaker: – Stanford Health Care
### @@@ Lisa Janssen Carlson, PharmD, BCOP (she/her/hers) – UCSF ### 2127664###Co-Speaker###Investigational Drug Services Manager###UCSF###Co-Speaker: – UCSF
### she/her/hers
1:15 PM – 2:30 PM ET
Updates in Hematology
1:15 PM – 2:30 PM ET
101 - Updates in HematologyLocation: Ballroom DSpeaker: – Methodist University Hospital
Dennis Marjoncu, PharmD, BCOP (he/him/his) – Methodist University Hospital ### 1171480###Speaker###Clinical Pharmacy Specialist###Methodist University Hospital###Speaker: – Methodist University Hospital
### he/him/his
2:45 PM – 3:30 PM ET
President's Welcome
2:45 PM – 3:30 PM ET
President's Welcome and Recognition of HOPA FellowsLocation: Ballroom B-C*Speaker: – Atrium Health Wake Forest Baptist (WFB)
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA – Atrium Health Wake Forest Baptist (WFB) ### 1311883###*Speaker###Clinical Specialist - Stem Cell Transplant and Cellular Therapy###Atrium Health Wake Forest Baptist (WFB)###*Speaker: – Atrium Health Wake Forest Baptist (WFB)
### 3:45 PM – 4:45 PM ET
Platform Research Part 1 of 4: The REMEDY Trial: Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy
3:45 PM – 4:45 PM ET
102-A - Platform Research Part 1 of 4: The REMEDY Trial: Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation ChemotherapyLocation: Ballroom DCo-Speaker: – University of Georgia College of Pharmacy
Co-Speaker: – Wellstar MCG Health
Amber Bradley Clemmons, PharmD, BCOP, FHOPA (she/her/hers) – University of Georgia College of Pharmacy ### 1177736###Co-Speaker###Clinical Professor###University of Georgia College of Pharmacy###Co-Speaker: – University of Georgia College of Pharmacy
### she/her/hers @@@ Emily Behren Ketchum, PharmD, BCOP (she/her/hers) – Wellstar MCG Health ### 1553112###Co-Speaker###Heme/BMT Ambulatory Oncology Pharmacy Specialist ###Wellstar MCG Health###Co-Speaker: – Wellstar MCG Health
### she/her/hers
3:45 PM – 4:45 PM ET
Platform Research Part 2 of 4: Post-Transplant Cyclophosphamide As GVHD Prevention After Myeloablative Conditioning
3:45 PM – 4:45 PM ET
102-B - Platform Research Part 2 of 4: Post-Transplant Cyclophosphamide As GVHD Prevention After Myeloablative ConditioningLocation: Ballroom DCo-Speaker: – Duke University Hospital
Co-Speaker: – Duke University Hospital
Mary C. Cash, PharmD, BCOP – Duke University Hospital ### 1553147###Co-Speaker###Clinical Oncology Pharmacist, Adult Bone Marrow Transplant and Cellular Therapy###Duke University Hospital###Co-Speaker: – Duke University Hospital
### @@@ Erin M. Eberwein, PharmD, BCOP – Duke University Hospital ### 2229003###Co-Speaker###Clinical Oncology Pharmacist, Bone Marrow Transplant and Cellular Therapy###Duke University Hospital###Co-Speaker: – Duke University Hospital
###
3:45 PM – 4:45 PM ET
Platform Research Part 3 of 4: Survey of PGY-2 Oncology RPDs To Assess Resources and Effects on Burnout
3:45 PM – 4:45 PM ET
102-C - Platform Research Part 3 of 4: Survey of PGY-2 Oncology RPDs To Assess Resources and Effects on BurnoutLocation: Ballroom DSpeaker: – Roswell Park Comprehensive Cancer Center
Eugene R. Przespolewski, PharmD, BCOP, DPLA (he/him/his) – Roswell Park Comprehensive Cancer Center ### 2188549###Speaker###Clinical Pharmacist Specialist, Residency Program Director###Roswell Park Comprehensive Cancer Center###Speaker: – Roswell Park Comprehensive Cancer Center
### he/him/his
3:45 PM – 4:45 PM ET
Platform Research Part 4 of 4: Predictive Factors of Dose Reduction Among Patients Treated With Palbociclib
3:45 PM – 4:45 PM ET
102-D - Platform Research Part 4 of 4: Predictive Factors of Dose Reduction Among Patients Treated With PalbociclibLocation: Ballroom DSpeaker: – CIUSSS de l'Est-de-l'Île-de-Montréal
Sandra Savignac, PharmD, M.Sc (she/her/hers) – CIUSSS de l'Est-de-l'Île-de-Montréal ### 2188537###Speaker###Oncology Pharmacist###CIUSSS de l'Est-de-l'Île-de-Montréal###Speaker: – CIUSSS de l'Est-de-l'Île-de-Montréal
### she/her/hers
3:45 PM – 4:45 PM ET
Updates in Hodgkin Lymphoma and the Role of the Pharmacist in Management of Toxicities
3:45 PM – 4:45 PM ET
103 - Updates in Hodgkin Lymphoma and the Role of the Pharmacist in Management of ToxicitiesLocation: Ballroom ASpeaker: – University of Miami Sylvester Comprehensive Cancer Center
Co-Speaker: – Miami Cancer Institute | Baptist Health South Florida
Matthew Chui, PharmD, BCOP – University of Miami Sylvester Comprehensive Cancer Center ### 2144501###Speaker###Clinical Oncology Pharmacy Manager###University of Miami Sylvester Comprehensive Cancer Center###Speaker: – University of Miami Sylvester Comprehensive Cancer Center
### @@@ Tiba Al Sagheer, PharmD, BCOP, BCACP (she/her/hers) – Miami Cancer Institute | Baptist Health South Florida ### 2144502###Co-Speaker###Clinical Pharmacy Specialist###Miami Cancer Institute | Baptist Health South Florida###Co-Speaker: – Miami Cancer Institute | Baptist Health South Florida
### she/her/hers
3:45 PM – 4:45 PM ET
Waiting For The Rain: Practical Strategies And Ethical Considerations During Anticancer Drug Droughts
3:45 PM – 4:45 PM ET
104 - Waiting For The Rain: Practical Strategies And Ethical Considerations During Anticancer Drug Droughts Location: Ballroom B-CCo-Speaker: – Aurora Heath Care
Co-Speaker: – The Ohio State University Wexner Medical Center
Co-Speaker:
Peter Stuessy, PharmD, BCOP (he/him/his) – Aurora Heath Care ### 2127674###Co-Speaker###Clinical Pharmacy Specialist - Oncology###Aurora Heath Care###Co-Speaker: – Aurora Heath Care
### he/him/his @@@ Jeff Pilz, PharmD, BCPS, MPA, MS – The Ohio State University Wexner Medical Center ### 1518389###Co-Speaker###Assistant Director of Pharmacy - Medication Safety and Policy###The Ohio State University Wexner Medical Center###Co-Speaker: – The Ohio State University Wexner Medical Center
### @@@ Michael Harrison ### 2188452###Co-Speaker###Patient Advocate and Cancer Survivor######Co-Speaker:
###
4:45 PM – 7:00 PM ET
Exhibit Hall Welcome Reception and Industry Encore Posters
4:45 PM – 7:00 PM ET
Exhibit Hall Welcome Reception and Industry Encore Posters
Location: Exhibit Hall
5:30 PM – 6:30 PM ET
Non-CE Symposium: Managing Patients with locally advanced or metastatic KRAS G12C-mutated NSCLC
5:30 PM – 6:30 PM ET
Non-CE Symposium: Managing Patients with locally advanced or metastatic KRAS G12C-mutated NSCLCLocation: 122-123
Hatim Husain, MD ### 2262370###*Speaker#########*Speaker:
### 5:30 PM – 6:30 PM ET
Non-CE Symposium: Planning for Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Case-Based Symposium on Care Team Preparation and Patient Management
5:30 PM – 6:30 PM ET
Non-CE Symposium: Planning for Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Case-Based Symposium on Care Team Preparation and Patient Management Location: 120-121*Speaker: – Menarini Stemline
*Speaker: – Menarini Stemline
Rebecca Nelson, PharmD, BCOP – Menarini Stemline ### 2251093###*Speaker######Menarini Stemline###*Speaker: – Menarini Stemline
### @@@ Dylan Barth, PharmD – Menarini Stemline ### 2251095###*Speaker######Menarini Stemline###*Speaker: – Menarini Stemline
### 6:00 PM – 8:00 PM ET
AC24 Service Project: HOPA CAN Help Prevent HIV
6:00 PM – 8:00 PM ET
AC24 Service Project: HOPA CAN Help Prevent HIV
Location: 118 - 119
- Thursday, April 4, 2024
6:15 AM – 7:30 AM ET
5K Fun Run
6:15 AM – 7:30 AM ET
5K Run for Cancer Research
7:00 AM – 8:00 AM ET
Non-CE Symposium: Key Considerations for Operationalizing Bispecifics in Relapsed or Refractory Multiple Myeloma
7:00 AM – 8:00 AM ET
Non-CE Symposium: Key Considerations for Operationalizing Bispecifics in Relapsed or Refractory Multiple MyelomaLocation: 120-121*Speaker: – Minnesota Oncology
Kirollos Hanna, PharmD, BCPS, BCOP, FACCC – Minnesota Oncology ### 894762###*Speaker###Director of Pharmacy###Minnesota Oncology###*Speaker: – Minnesota Oncology
### 7:00 AM – 8:00 AM ET
Non-CE Symposium: Essentials for Pharmacists: A Treatment Option for Relapsed or Refractory Multiple Myeloma From Pfizer
7:00 AM – 8:00 AM ET
Non-CE Symposium: Essentials for Pharmacists: A Treatment Option for Relapsed or Refractory Multiple Myeloma From PfizerLocation: 124-125*Speaker: – USC Norris Comprehensive Cancer Center
Amir Ali, PharmD – USC Norris Comprehensive Cancer Center ### 1252116###*Speaker###PGY-2 Oncology Resident###USC Norris Comprehensive Cancer Center###*Speaker: – USC Norris Comprehensive Cancer Center
### 7:00 AM – 8:00 AM ET
Non-CE Symposium: Managing Myelofibrosis: A Pharmacist’s Perspective
7:00 AM – 8:00 AM ET
Non-CE Symposium: Managing Myelofibrosis: A Pharmacist’s PerspectiveLocation: 122-123*Speaker: – The Mount Sinai Hospital
Kyle Farina, PharmD, BCPS, BCOP – The Mount Sinai Hospital ### 2251097###*Speaker######The Mount Sinai Hospital###*Speaker: – The Mount Sinai Hospital
### 7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Geriatric
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Geriatric
Location: 116
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - New Practitioner
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - New Practitioner
Location: 114
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Pediatrics
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Pediatrics
Location: 117
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Precision Health in Oncology
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Precision Health in OncologyLocation: 113
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Transplant & Cellular Therapy
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Transplant & Cellular Therapy
Location: 115
8:15 AM – 9:30 AM ET
CAR T-Cell Breakthroughs in Lymphoma and Myeloma: Balancing Efficacy and Safety
8:15 AM – 9:30 AM ET
BC2 - CAR T-Cell Breakthroughs in Lymphoma and Myeloma: Balancing Efficacy and SafetyLocation: Ballroom B-CSpeaker: – The University of Texas MD Anderson Cancer Center
Brian Primeaux, PharmD, BCOP (he/him/his) – The University of Texas MD Anderson Cancer Center ### 1774213###Speaker###Clinical Pharmacy Specialist, Lymphoma/Myeloma/CAR-T###The University of Texas MD Anderson Cancer Center###Speaker: – The University of Texas MD Anderson Cancer Center
### he/him/his
8:15 AM – 9:30 AM ET
Moving Beyond One Size Fits All for Solid Tumors: Updates in Biomarker Driven Therapies
8:15 AM – 9:30 AM ET
201 - Moving Beyond One Size Fits All for Solid Tumors: Updates in Biomarker Driven Therapies Location: Ballroom ACo-Speaker: – Memorial Sloan Kettering Cancer Center
Co-Speaker: – Memorial Sloan Kettering Cancer Center
Raymond DeMatteo, PharmD, BCOP – Memorial Sloan Kettering Cancer Center ### 947774###Co-Speaker###Clinical Pharmacy Specialist###Memorial Sloan Kettering Cancer Center###Co-Speaker: – Memorial Sloan Kettering Cancer Center
### @@@ Adam Kahleifeh, PharmD, BCOP – Memorial Sloan Kettering Cancer Center ### 1252155###Co-Speaker###Clinical Pharmacy Specialist###Memorial Sloan Kettering Cancer Center###Co-Speaker: – Memorial Sloan Kettering Cancer Center
###
9:40 AM – 10:40 AM ET
1 - To Transplant or Not to Transplant: Current Treatment Approaches for Mantle Cell Lymphoma
9:40 AM – 10:40 AM ET
202-A - To Transplant or Not to Transplant: Current Treatment Approaches for Mantle Cell LymphomaLocation: Ballroom ASpeaker: – University of Illinois Chicago
Michael Buege, PharmD, BCOP – University of Illinois Chicago ### 2127671###Speaker###Clinical Assistant Professor###University of Illinois Chicago###Speaker: – University of Illinois Chicago
###
9:40 AM – 10:40 AM ET
2 - Baby Steps: Updates in the Treatment of Infant Leukemia
9:40 AM – 10:40 AM ET
202-B - Baby Steps: Updates in the Treatment of Infant LeukemiaLocation: Ballroom A
Catherine Martin, PharmD, BCOP (she/her/hers) – Mayo Clinic ### 1808423###Speaker###Pediatric Hematology/Oncology Ambulatory Care Pharmacist###Mayo Clinic###Speaker: – Mayo Clinic
### she/her/hers
9:40 AM – 10:40 AM ET
3 - Advances in Targeted Therapies for Gastrointestinal Malignancies
9:40 AM – 10:40 AM ET
203-A - Advances in Targeted Therapies for Gastrointestinal MalignanciesLocation: Ballroom DSpeaker: – Moffitt Cancer Center
Sarah Chehab, PharmD, BCOP (she/her/hers) – Moffitt Cancer Center ### 2127678###Speaker###Clinical Pharmacy Specialist- Medical Oncology###Moffitt Cancer Center###Speaker: – Moffitt Cancer Center
### she/her/hers
9:40 AM – 10:40 AM ET
4 - Targeting HER2 Alterations in Patients With Non-Breast/Non-Gastric Cancers
9:40 AM – 10:40 AM ET
203-B - Targeting HER2 Alterations in Patients With Non-Breast/Non-Gastric CancersLocation: Ballroom DSpeaker: – Memorial Sloan Kettering Cancer Center
Dazhi Liu, PharmD, BCOP – Memorial Sloan Kettering Cancer Center ### 2127675###Speaker###Clinical Pharmacy Specialist###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
###
9:40 AM – 10:40 AM ET
5 - Show Me the Money: Optimizing the Electronic Medical Record (EMR) to Improve Biosimilar Utilization and Pharmacy Reimbursement
9:40 AM – 10:40 AM ET
204-A - Show Me the Money: Optimizing the Electronic Medical Record (EMR) to Improve Biosimilar Utilization and Pharmacy ReimbursementLocation: Ballroom B-CSpeaker: – The University of Kansas Health System
Nikki R. Ogle, PharmD, BCOP (she/her/hers) – The University of Kansas Health System ### 2127662###Speaker###Oncology Reimbursement Pharmacist, Team Lead###The University of Kansas Health System###Speaker: – The University of Kansas Health System
### she/her/hers
9:40 AM – 10:40 AM ET
6 - Cannabinoids and the Oncology Patient: Pearls for Pharmacists
9:40 AM – 10:40 AM ET
204-B - Cannabinoids and the Oncology Patient: Pearls for PharmacistsLocation: Ballroom B-C
Marie Parish, PharmD, BCOP, BCPS (she/her/hers) – Mayo Clinic ### 2127683###Speaker###Clinical Oncology Pharmacist###Mayo Clinic###Speaker: – Mayo Clinic
### she/her/hers
10:50 AM – 11:50 AM ET
Member Awards & Business Meeting
10:50 AM – 11:50 AM ET
Member Awards & Business MeetingLocation: Ballroom B-C*Speaker: – Atrium Health Wake Forest Baptist (WFB)
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA – Atrium Health Wake Forest Baptist (WFB) ### 1311883###*Speaker###Clinical Specialist - Stem Cell Transplant and Cellular Therapy###Atrium Health Wake Forest Baptist (WFB)###*Speaker: – Atrium Health Wake Forest Baptist (WFB)
### 11:50 AM – 2:15 PM ET
Exhibit Hall and Lunch
11:50 AM – 2:15 PM ET
Exhibit Hall and Lunch
Location: Exhibit Hall
12:00 PM – 1:00 PM ET
CE Symposium: Advancements in Early-Stage Breast Cancer: The Role of Oncology Pharmacists in Treatment Optimization
12:00 PM – 1:00 PM ET
CE Symposium: Advancements in Early-Stage Breast Cancer: The Role of Oncology Pharmacists in Treatment OptimizationLocation: 122-123Co-Speaker: – Allegheny Health Network
Co-Speaker: – UK HealthCare
Co-Speaker:
Danielle Roman, PharmD, BCOP (she/her/hers) – Allegheny Health Network ### 2127689###Co-Speaker###Manager, Oncology Clinical Pharmacy Services###Allegheny Health Network###Co-Speaker: – Allegheny Health Network
### she/her/hers @@@ Allison Butts, PharmD, BCOP – UK HealthCare ### 1491239###Co-Speaker###Clinical Coordinator-Medical Oncology; PGY2 Pharmacy Residency Program Director- Oncology###UK HealthCare###Co-Speaker: – UK HealthCare
### @@@ Julia Ziegengeist, PharmD, BCOP ### 2269371###Co-Speaker#########Co-Speaker:
### 12:00 PM – 1:00 PM ET
CE Symposium: Elevating Safety and Adherence in Chronic Myeloid Leukemia Through Oncology Pharmacist Expertise
12:00 PM – 1:00 PM ET
CE Symposium: Elevating Safety and Adherence in Chronic Myeloid Leukemia Through Oncology Pharmacist ExpertiseLocation: 120-121Co-Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center
Co-Speaker: – Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
Co-Speaker:
Peter Campbell, PharmD, MBA, BCOP – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center ### 1589099###Co-Speaker######NewYork-Presbyterian Hospital, Columbia University Irving Medical Center###Co-Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center
### @@@ Benyam Muluneh, Pharm.D., BCOP, CPP – Eshelman School of Pharmacy, University of North Carolina at Chapel Hill ### 1137104###Co-Speaker###Assistant Professor###Eshelman School of Pharmacy, University of North Carolina at Chapel Hill###Co-Speaker: – Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
### @@@ Jordan Snyder, PharmD, BCOP ### 2262350###Co-Speaker#########Co-Speaker:
### 12:00 PM – 1:00 PM ET
CE Symposium: What’s New in NSCLC Therapies? Key Takeaways for Your Pharmacy Practice
12:00 PM – 1:00 PM ET
CE Symposium: What’s New in NSCLC Therapies? Key Takeaways for Your Pharmacy PracticeLocation: 124-125
Val Adams, PharmD FCCP BCOP ### 957909###*Speaker###Associate Professor, University of Kentucky######*Speaker:
### @@@ Whitney Lewis, PharmD, BCOP ### 2238585###*Speaker###Clinical Pharmacy Specialist, The University of Texas, MD Anderson Cancer Center######*Speaker:
### 12:00 PM – 1:00 PM ET
Leadership Development Roundtable: Career Ladders and Professional Development Plans
12:00 PM – 1:00 PM ET
Leadership Development Roundtable: Career Ladders and Professional Development Plans
Location: 118 - 119
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Academia
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Academia
Location: 114
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Administration
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Administration
Location: 115
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Epic (Beacon) Users
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Epic (Beacon) Users
Location: 116
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Gynecologic Oncology
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Gynecologic Oncology
Location: 117
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Specialty Pharmacy
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Specialty Pharmacy
Location: 113
1:00 PM – 2:00 PM ET
Annual Advocacy Update
1:00 PM – 2:00 PM ET
Annual Advocacy UpdateLocation: Ballroom B-C*Speaker: – HOPA
*Speaker: – The Brooklyn Cancer Center
*Speaker: – CRD Associates
Brooke Boring, MPH, CPhT (she/her/hers) – HOPA ### 1518390###*Speaker###Senior Manager of Health Policy & Advocacy###HOPA###*Speaker: – HOPA
### she/her/hers @@@ Lilia Davenport, PharmD, BCPS, BCOP (she/her/hers) – The Brooklyn Cancer Center ### 1553029###*Speaker###Clinical Pharmacy Manager and Oncology Pharmacotherapy Specialist ###The Brooklyn Cancer Center ###*Speaker: – The Brooklyn Cancer Center
### she/her/hers @@@ Jeremy Scott, MA – CRD Associates ### 969263###*Speaker###Senior Vice President###CRD Associates###*Speaker: – CRD Associates
### 2:15 PM – 3:30 PM ET
Debating the Incorporation of Novel Therapies in Front-Line Acute Lymphoblastic Leukemia Treatment
2:15 PM – 3:30 PM ET
205 - Debating the Incorporation of Novel Therapies in Front-Line Acute Lymphoblastic Leukemia TreatmentLocation: Ballroom ASpeaker: – University of Utah Huntsman Cancer Institute
Co-Speaker: – University of Utah Huntsman Cancer Institute
Charlotte B. Wagner, PharmD, BCOP (she/her/hers) – University of Utah Huntsman Cancer Institute ### 2127679###Speaker###Clinical Pharmacist###University of Utah Huntsman Cancer Institute###Speaker: – University of Utah Huntsman Cancer Institute
### she/her/hers @@@ Taylor Kujawa, PharmD (she/her/hers) – University of Utah Huntsman Cancer Institute ### 2127680###Co-Speaker###Clinical Pharmacist###University of Utah Huntsman Cancer Institute###Co-Speaker: – University of Utah Huntsman Cancer Institute
### she/her/hers
2:15 PM – 3:30 PM ET
The Great Financial Debate: Cost vs Margin for Cancer Care Drugs
2:15 PM – 3:30 PM ET
BC3 - The Great Financial Debate: Cost vs Margin for Cancer Care DrugsLocation: Ballroom B-CCo-Speaker: – Mayo Clinic
Co-Speaker: – Mayo Clinic
Scott A. Soefje, PharmD, BCOP, FCCP, FHOPA, MBA (he/him/his) – Mayo Clinic ### 894791###Co-Speaker###Director, Pharmacy Cancer Care###Mayo Clinic###Co-Speaker: – Mayo Clinic
### he/him/his @@@ Chelsee J. Jensen, PharmD, BCPS, P-RCM (she/her/hers) – Mayo Clinic ### 2127682###Co-Speaker###Senior Pharmacy Specialist- Pharmaceutical Formulary Manager###Mayo Clinic###Co-Speaker: – Mayo Clinic
### she/her/hers
3:45 PM – 4:45 PM ET
New Practitioner’s Guide to Navigating Your Career
3:45 PM – 4:45 PM ET
206 - New Practitioner’s Guide to Navigating Your CareerLocation: Ballroom ACo-Speaker: – MD Anderson Cancer Center, Houston, TX
Co-Speaker: – Golisano Children's Hospital
Co-Speaker: – VCU Health System, Richmond VA
Co-Speaker: – UT MD Anderson Cancer Center
Alison M. Gulbis, PharmD, BCOP (she/her/hers) – MD Anderson Cancer Center, Houston, TX ### 1637191###Co-Speaker###Clinical Pharmacy Manager###MD Anderson Cancer Center, Houston, TX###Co-Speaker: – MD Anderson Cancer Center, Houston, TX
### she/her/hers @@@ Jordan Wallace, PharmD, BCOP, CPh (she/her/hers) – Golisano Children's Hospital ### 1553108###Co-Speaker###Pediatric Oncology Pharmacy Clinical Specialist###Golisano Children's Hospital###Co-Speaker: – Golisano Children's Hospital
### she/her/hers @@@ Matthew Peery, PharmD (he/him/his) – VCU Health System, Richmond VA ### 1897695###Co-Speaker###Oncology Clinical Pharmacy Specialist###VCU Health System, Richmond VA###Co-Speaker: – VCU Health System, Richmond VA
### he/him/his @@@ Emma Garrison, PharmD, BCOP – UT MD Anderson Cancer Center ### 2128386###Co-Speaker###Oncology Clinical Pharmacy Specialist###UT MD Anderson Cancer Center###Co-Speaker: – UT MD Anderson Cancer Center
###
3:45 PM – 4:45 PM ET
Nuances in Neuro-Oncology: Glioma Treatment Advances and New Diagnostic
3:45 PM – 4:45 PM ET
BC4 - Nuances in Neuro-Oncology: Glioma Treatment Advances and New Diagnostic Definitions ("BCOP 101" format)Location: Ballroom B-CSpeaker: – Huntsman Cancer Institute
Kelly A. Fritz, PharmD, BCOP (she/her/hers) – Huntsman Cancer Institute ### 2010623###Speaker###Clinical Coordinator###Huntsman Cancer Institute###Speaker: – Huntsman Cancer Institute
### she/her/hers
3:45 PM – 4:45 PM ET
REACHing for ROCKstars –iNTEGRATing Updates in Chronic Graft Versus Host Disease
3:45 PM – 4:45 PM ET
207 - REACHing for ROCKstars –iNTEGRATing Updates in Chronic Graft Versus Host DiseaseLocation: Ballroom DSpeaker: – Oregon Health and Sciences University
Shannon E. Palmer, PharmD, BCOP (she/her/hers) – Oregon Health and Sciences University ### 1252219###Speaker###Hematology and Bone Marrow Transplant Pharmacist###Oregon Health and Sciences University###Speaker: – Oregon Health and Sciences University
### she/her/hers
4:45 PM – 7:30 PM ET
Exhibit Hall Evening Reception
4:45 PM – 7:30 PM ET
Exhibit Hall Evening Reception
Location: Exhibit Hall
5:00 PM – 6:00 PM ET
Diversity + Belonging Reception
5:00 PM – 6:00 PM ET
Diversity + Belonging Reception
Location: 118 - 119
5:00 PM – 7:30 PM ET
E-Poster Presentations: Completed Research and Trainee Top Ten
5:00 PM – 7:30 PM ET
E-Poster Presentations: Completed Research and Trainee Top Ten
Location: Exhibit Hall
5:30 PM – 6:30 PM ET
Non-CE Symposium: Review of Evidence-Based Data for an Antibody-Drug Conjugate in Combination With a PD-1 Inhibitor for 1L la/mUC
5:30 PM – 6:30 PM ET
Non-CE Symposium: Review of Evidence-Based Data for an Antibody-Drug Conjugate in Combination With a PD-1 Inhibitor for 1L la/mUCLocation: 122-123
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP ### 957901###*Speaker#########*Speaker:
### 5:30 PM – 6:30 PM ET
Non-CE Symposium: EMERALD study update: Exploring the safety and efficacy data in patients with ER+/HER2, ESR1-mutated mBC, including data from subgroup analyses
5:30 PM – 6:30 PM ET
Non-CE Symposium: EMERALD study update: Exploring the safety and efficacy data in patients with ER+/HER2, ESR1-mutated mBC, including data from subgroup analysesLocation: 120-121*Speaker: – Menarini Stemline
Scott Ostriker, PharmD, MBA, BCOP – Menarini Stemline ### 2251099###*Speaker######Menarini Stemline###*Speaker: – Menarini Stemline
### 6:00 PM – 8:00 PM ET
IRC Reception (Invite Only)
6:00 PM – 8:00 PM ET
IRC Reception (Invite Only)
- Friday, April 5, 2024
6:30 AM – 7:30 AM ET
Yoga
6:30 AM – 7:30 AM ET
Easy Flow Yoga
Location: 111 - 112
7:00 AM – 8:00 AM ET
CE Symposium: Maximizing Efficacy and Minimizing Toxicity of ADCs Targeting HER2, HER3 and TROP2: Strategies for Oncology Pharmacists
7:00 AM – 8:00 AM ET
CE Symposium: Maximizing Efficacy and Minimizing Toxicity of ADCs Targeting HER2, HER3 and TROP2: Strategies for Oncology PharmacistsLocation: 124-125*Speaker: – UK HealthCare
*Speaker:
Allison Butts, PharmD, BCOP – UK HealthCare ### 1491239###*Speaker###Clinical Coordinator-Medical Oncology; PGY2 Pharmacy Residency Program Director- Oncology###UK HealthCare###*Speaker: – UK HealthCare
### @@@ Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP ### 957901###*Speaker#########*Speaker:
### 7:00 AM – 8:00 AM ET
CE Symposium: Navigating Chronic Lymphocytic Leukemia Therapy and Cardiovascular Comorbidities: Clinical Recommendations and Safety Measures
7:00 AM – 8:00 AM ET
CE Symposium: Navigating Chronic Lymphocytic Leukemia Therapy and Cardiovascular Comorbidities: Clinical Recommendations and Safety MeasuresLocation: 120-121Co-Speaker: – Medical University of South Carolina
Co-Speaker: – University of Miami Sylvester Comprehensive Cancer Center
Co-Speaker: – University of Illinois Chicago
James A. Davis, PharmD, BCOP – Medical University of South Carolina ### 1810470###Co-Speaker###Clinical Pharmacy Specialist – Malignant Hematology & Assistant Professor - MUSC College of Pharmacy###Medical University of South Carolina###Co-Speaker: – Medical University of South Carolina
### @@@ Matthew Chui, PharmD, BCOP – University of Miami Sylvester Comprehensive Cancer Center ### 2144501###Co-Speaker###Clinical Oncology Pharmacy Manager###University of Miami Sylvester Comprehensive Cancer Center###Co-Speaker: – University of Miami Sylvester Comprehensive Cancer Center
### @@@ Michael Buege, PharmD, BCOP – University of Illinois Chicago ### 2127671###Co-Speaker###Clinical Assistant Professor###University of Illinois Chicago###Co-Speaker: – University of Illinois Chicago
### 7:00 AM – 8:00 AM ET
CE Symposium: Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based Care
7:00 AM – 8:00 AM ET
CE Symposium: Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based CareLocation: 122-123Co-Speaker:
Co-Speaker: – Memorial Sloan Kettering Cancer Center
Co-Speaker:
Sara Moran Smith, PharmD, BCOP ### 2269382###Co-Speaker#########Co-Speaker:
### @@@ Sarah E. Profitt, PharmD, BCPS, BCOP – Memorial Sloan Kettering Cancer Center ### 1195640###Co-Speaker###Clinical Pharmacy Specialist - Leukemia###Memorial Sloan Kettering Cancer Center###Co-Speaker: – Memorial Sloan Kettering Cancer Center
### @@@ Julio Chavez, MD ### 2269383###Co-Speaker#########Co-Speaker:
### 7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Ambulatory
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Ambulatory
Location: 116
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Breast Cancer
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Breast Cancer
Location: 117
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Cerner Oncology Users
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Cerner Oncology Users
Location: 114
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Industry Professionals
7:00 AM – 8:00 AM ET
Special Interest Group (SIG) - Industry Professionals
Location: 115
8:15 AM – 9:30 AM ET
New Flavors: Bites in Hematologic Malignancies
8:15 AM – 9:30 AM ET
301 - New Flavors: Bites in Hematologic MalignanciesLocation: Ballroom ACo-Speaker: – OhioHealth Riverside Methodist Hospital
Co-Speaker: – Stanford Healthcare
Co-Speaker: – Dana-Farber Cancer Institute
Co-Speaker: – WVU Medicine
Melissa Royero, PharmD (she/her/hers) – OhioHealth Riverside Methodist Hospital ### 1252279###Co-Speaker###Clinical Oncology Pharmacist###OhioHealth Riverside Methodist Hospital###Co-Speaker: – OhioHealth Riverside Methodist Hospital
### she/her/hers @@@ Soniya Chandrasekhara, PharmD., BCOP (she/her/hers) – Stanford Healthcare ### 2127681###Co-Speaker###Clinical Pharmacist - Adult Hematology/Oncology###Stanford Healthcare###Co-Speaker: – Stanford Healthcare
### she/her/hers @@@ Shahrier Hossain, PharmD, BCOP – Dana-Farber Cancer Institute ### 2127666###Co-Speaker###Clinical Pharmacy Specialist, Multiple Myeloma###Dana-Farber Cancer Institute###Co-Speaker: – Dana-Farber Cancer Institute
### @@@ Kelsea Seago, PharmD, BCOP (she/her/hers) – WVU Medicine ### 2161000###Co-Speaker###Clinical Pharmacy Specialist, TCT/Hematologic Malignancies###WVU Medicine###Co-Speaker: – WVU Medicine
### she/her/hers
8:15 AM – 9:30 AM ET
Pharmacology and Clinical Application of Complement Inhibitors
8:15 AM – 9:30 AM ET
BC5 - Pharmacology and Clinical Application of Complement InhibitorsLocation: Ballroom B-CCo-Speaker: – Memorial Sloan Kettering Cancer Center
Co-Speaker: – Specialty Pharmacy Service, Atrium Health
Binni Kunvarjee, PharmD, BCOP (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 895372###Co-Speaker###Clinical Pharmacy Specialist###Memorial Sloan Kettering Cancer Center###Co-Speaker: – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Justin R. Arnall, PharmD, BCOP – Specialty Pharmacy Service, Atrium Health ### 1792810###Co-Speaker###Clinical Coordinator, Hematology###Specialty Pharmacy Service, Atrium Health###Co-Speaker: – Specialty Pharmacy Service, Atrium Health
###
9:40 AM – 10:40 AM ET
1 - Ethical Dilemmas in Oncology Pharmacy: When Science and Morals Collide
9:40 AM – 10:40 AM ET
302-A - Ethical Dilemmas in Oncology Pharmacy: When Science and Morals CollideLocation: Ballroom B-CSpeaker: – Duquesne University School of Pharmacy
Karen M. Fancher, PharmD, BCOP – Duquesne University School of Pharmacy ### 2127686###Speaker###Associate Professor of Pharmacy Practice###Duquesne University School of Pharmacy###Speaker: – Duquesne University School of Pharmacy
###
9:40 AM – 10:40 AM ET
2 - The Gene Therapy Odyssey: Preparing the Pharmacist for New Horizons
9:40 AM – 10:40 AM ET
302-B - The Gene Therapy Odyssey: Preparing the Pharmacist for New HorizonsLocation: Ballroom B-CSpeaker: – CenterWell Specialty Pharmacy
Abby Kim, PharmD, BCOP (she/her/hers) – CenterWell Specialty Pharmacy ### 2127673###Speaker###Clinical Pharmacy Lead, Cell and Gene Therapy###CenterWell Specialty Pharmacy###Speaker: – CenterWell Specialty Pharmacy
### she/her/hers
9:40 AM – 10:40 AM ET
3 - Bispecifics in Lymphoma
9:40 AM – 10:40 AM ET
303-A - Bispecifics in LymphomaLocation: Ballroom ASpeaker: – Emory Winship Cancer Institute
Aseala Abousaud, PharmD, BCOP (she/her/hers) – Emory Winship Cancer Institute ### 1177743###Speaker###Oncology Clinical Pharmacy Specialist, Lymphoma###Emory Winship Cancer Institute###Speaker: – Emory Winship Cancer Institute
### she/her/hers
9:40 AM – 10:40 AM ET
4 - Taking a Bite Out of Myeloma: The Role of Bi-Specific Antibodies in the Treatment of Relapsed/Refractory Multiple Myeloma
9:40 AM – 10:40 AM ET
303-B - Taking a Bite Out of Myeloma: The Role of Bi-Specific Antibodies in the Treatment of Relapsed/Refractory Multiple MyelomaLocation: Ballroom ASpeaker: – Orlando Health Cancer Institute
Brooke Adams, PharmD, BCOP (she/her/hers) – Orlando Health Cancer Institute ### 2127668###Speaker###Clinical Pharmacy Specialist, Malignant Hematology/BMT/Cellular Therapy###Orlando Health Cancer Institute###Speaker: – Orlando Health Cancer Institute
### she/her/hers
9:40 AM – 10:40 AM ET
5 - Updates in the Management of Endometrial Cancer
9:40 AM – 10:40 AM ET
304-A - Updates in the Management of Endometrial CancerLocation: Ballroom DSpeaker: – Allegheny Health Network Cancer Institute
Emily Graham, PharmD, BCOP, MS (she/her/hers) – Allegheny Health Network Cancer Institute ### 1794908###Speaker###Clinical Pharmacy Specialist###Allegheny Health Network Cancer Institute###Speaker: – Allegheny Health Network Cancer Institute
### she/her/hers
9:40 AM – 10:40 AM ET
6 - Expanding the Use of CDK4/6 Inhibitors to Early-Stage Breast Cancer Treatment
9:40 AM – 10:40 AM ET
304-B - Expanding the Use of CDK4/6 Inhibitors to Early-Stage Breast Cancer TreatmentLocation: Ballroom DSpeaker: – Allegheny Health Network
Danielle Roman, PharmD, BCOP (she/her/hers) – Allegheny Health Network ### 2127689###Speaker###Manager, Oncology Clinical Pharmacy Services###Allegheny Health Network###Speaker: – Allegheny Health Network
### she/her/hers
10:50 AM – 11:50 AM ET
John G. Kuhn Keynote Address: Dr. Glaucomflecken "Wife & Death & Comedy"
10:50 AM – 11:50 AM ET
John G. Kuhn Keynote Address: Dr. Glaucomflecken "Wife & Death & Comedy"Location: Ballroom B-CKeynote Speaker: – Eye Health Northwest
Will "Dr. G" Flanary, MD – Eye Health Northwest ### 2055968###Keynote Speaker###Ophthalmologist###Eye Health Northwest###Keynote Speaker: – Eye Health Northwest
### 11:50 AM – 2:15 PM ET
Exhibit Hall and Lunch
11:50 AM – 2:15 PM ET
Exhibit Hall and Lunch
Location: Exhibit Hall
12:00 PM – 1:00 PM ET
Non-CE Symposium: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor.
12:00 PM – 1:00 PM ET
Non-CE Symposium: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor.Location: 124-125*Speaker: – Texas Southern University College of Pharmacy and Health Sciences
Rodney J. Hunter, PharmD, BCOP – Texas Southern University College of Pharmacy and Health Sciences ### 2251235###*Speaker######Texas Southern University College of Pharmacy and Health Sciences###*Speaker: – Texas Southern University College of Pharmacy and Health Sciences
### 12:00 PM – 1:00 PM ET
Non-CE Symposium: Practical Management of AML with a BCL-2 Inhibitor
12:00 PM – 1:00 PM ET
Non-CE Symposium: Practical Management of AML with a BCL-2 Inhibitor Location: 122-123
Cory Vela, PharmD, BCOP ### 2289648###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM ET
Non-CE Symposium: Understanding the role of pharmacists in the management of Low-risk Myelodysplastic Syndromes (MDS)
12:00 PM – 1:00 PM ET
Non-CE Symposium: Understanding the role of pharmacists in the management of Low-risk Myelodysplastic Syndromes (MDS)Location: 120-121
David Sallman, MD ### 2265849###Co-Speaker#########Co-Speaker:
### @@@ Katie Tobon, PharmD, BCOP ### 2265851###Co-Speaker#########Co-Speaker:
### 12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Classical Hematology
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Classical Hematology
Location: 117
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Investigational Drug Services (IDS)
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Investigational Drug Services (IDS)
Location: 115
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Residency Program Directors (RPD)
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Residency Program Directors (RPD)
Location: 114
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Trainee
12:00 PM – 1:00 PM ET
Special Interest Group (SIG) - Trainee
Location: 116
12:00 PM – 2:00 PM ET
Poster Session: Trainee Research
12:00 PM – 2:00 PM ET
Poster Session: Trainee Research
Location: Exhibit Hall
2:15 PM – 3:00 PM ET
Incoming President's Remarks
2:15 PM – 3:00 PM ET
Incoming President's RemarksLocation: Ballroom B-C*Speaker: – Charles George VA Medical Center
Jolynn K. Sessions, PharmD, BCOP, FHOPA – Charles George VA Medical Center ### 957905###*Speaker###Oncology Clinical Pharmacist Specialist, Oncology Pharmacy Manager###Charles George VA Medical Center###*Speaker: – Charles George VA Medical Center
### 3:15 PM – 4:15 PM ET
Aiming for the Bullseye: Updates in Pediatric Solid Tumor Precision Medicine
3:15 PM – 4:15 PM ET
BC6 - Aiming for the Bullseye: Updates in Pediatric Solid Tumor Precision Medicine Location: Ballroom B-CSpeaker: – Lake Erie College of Osteopathic Medicine School of Pharmacy
Tara Higgins, PharmD, BCPPS, FPPA, FFSHP (she/her/hers) – Lake Erie College of Osteopathic Medicine School of Pharmacy ### 2127672###Speaker###Assistant Professor###Lake Erie College of Osteopathic Medicine School of Pharmacy###Speaker: – Lake Erie College of Osteopathic Medicine School of Pharmacy
### she/her/hers
3:15 PM – 4:15 PM ET
Buzzworthy Bladder Breakthroughs: Updates in Metastatic Bladder Cancer
3:15 PM – 4:15 PM ET
305 - Buzzworthy Bladder Breakthroughs: Updates in Metastatic Bladder CancerLocation: Ballroom ASpeaker: – The University of Kansas Cancer Center
Kelly M. Brunk, PharmD, BCOP (he/him/his) – The University of Kansas Cancer Center ### 947775###Speaker###Clinical Oncology Pharmacist###The University of Kansas Cancer Center###Speaker: – The University of Kansas Cancer Center
### he/him/his
6:00 PM – 9:00 PM ET
HOPA's 20th Anniversary Gala
6:00 PM – 9:00 PM ET
HOPA's 20th Anniversary Celebration
- Saturday, April 6, 2024
7:00 AM – 8:00 AM ET
CE Symposium: Enhancing Bruton Tyrosine Kinase Inhibitor Outcomes in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: A Pharmacist's Roadmap to Success
7:00 AM – 8:00 AM ET
CE Symposium: Enhancing Bruton Tyrosine Kinase Inhibitor Outcomes in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: A Pharmacist's Roadmap to SuccessLocation: 122-123Co-Speaker: – Duquesne University School of Pharmacy
Co-Speaker:
Co-Speaker: – University of Maryland School of Pharmacy/University of Maryland Greenebaum Comprehensive Cancer Center
Karen M. Fancher, PharmD, BCOP – Duquesne University School of Pharmacy ### 2127686###Co-Speaker###Associate Professor of Pharmacy Practice###Duquesne University School of Pharmacy###Co-Speaker: – Duquesne University School of Pharmacy
### @@@ Melanie A. Rudisill, PharmD, BCOP ### 2269397###Co-Speaker#########Co-Speaker:
### @@@ Alison Duffy, PharmD BCOP – University of Maryland School of Pharmacy/University of Maryland Greenebaum Comprehensive Cancer Center ### 894756###Co-Speaker###Associate Professor/Oncology Clinical Pharmacy Specialist###University of Maryland School of Pharmacy/University of Maryland Greenebaum Comprehensive Cancer Center###Co-Speaker: – University of Maryland School of Pharmacy/University of Maryland Greenebaum Comprehensive Cancer Center
### 7:00 AM – 8:00 AM ET
CE Symposium: New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes (LR-MDS): Bridging Clinical Innovation and Practice
7:00 AM – 8:00 AM ET
CE Symposium: New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes (LR-MDS): Bridging Clinical Innovation and PracticeLocation: 120-121Co-Speaker: – University of Michigan
Co-Speaker:
Co-Speaker:
Anthony J. Perissinotti, PharmD, BCOP – University of Michigan ### 1486423###Co-Speaker###Clinical Pharmacist Specialist - Hematology###University of Michigan###Co-Speaker: – University of Michigan
### @@@ Firas El Chaer, MD ### 2269390###Co-Speaker#########Co-Speaker:
### @@@ Rachel Feaster, PharmD, BCOP, BCPS ### 2269393###Co-Speaker#########Co-Speaker:
### 8:15 AM – 9:15 AM ET
Up to My Neck (In Head and Neck Cancer Updates)
8:15 AM – 9:15 AM ET
BC7 - Up to My Neck (In Head and Neck Cancer Updates)Location: Ballroom B-C
Christine Barrett, PharmD, BCOP (she/her/hers) – WVU Medicine ### 947617###Speaker###Oncology Pharmacy Specialist, Ambulatory Solid Tumor###WVU Medicine###Speaker: – WVU Medicine
### she/her/hers
8:15 AM – 9:15 AM ET
1 - Clinical Pearl 1: Challenging the Recognition and Treatment Management for HER2-low Breast Cancer
8:15 AM – 9:15 AM ET
401-A - Clinical Pearl 1: Challenging the Recognition and Treatment Management for HER2-low Breast CancerLocation: Ballroom ASpeaker: – Baptist Health Lexington
Megan May, PharmD, BCOP, FHOPA, FAPO – Baptist Health Lexington ### 894748###Speaker###Clinical Oncology Pharmacy Specialist###Baptist Health Lexington###Speaker: – Baptist Health Lexington
###
8:15 AM – 9:15 AM ET
2 - Clinical Pearl 2: Best Practices – Management of Alpelisib-Induced Hyperglycemia
8:15 AM – 9:15 AM ET
401-B - Clinical Pearl 2: Best Practices – Management of Alpelisib-Induced HyperglycemiaLocation: Ballroom ASpeaker: – Billings Clinic
Marie E. Sirek, PharmD, BCACP, CPP – Billings Clinic ### 2127663###Speaker###Clinical Pharmacy Specialist - Oral Oncology###Billings Clinic###Speaker: – Billings Clinic
###
8:15 AM – 9:15 AM ET
3 - Clinical Pearl 3: Metastatic Castrate Resistant Prostate Cancer in a State of (Homologous Recombination) Repair: Navigating PARPi Therapy Selection
8:15 AM – 9:15 AM ET
401-C - Clinical Pearl 3: Metastatic Castrate Resistant Prostate Cancer in a State of (Homologous Recombination) Repair: Navigating PARPi Therapy SelectionLocation: Ballroom ASpeaker: – Advocate Health
Mary Walters, PharmD, BCOP – Advocate Health ### 1795273###Speaker###Co-Director Oncology Precision Medicine###Advocate Health###Speaker: – Advocate Health
###
9:25 AM – 10:25 AM ET
1 - To Treat or Not To Treat? The Role of Immunotherapy in Non Small Cell Lung Cancer (NSCLC) With Oncogenic Drivers
9:25 AM – 10:25 AM ET
402 - To Treat or Not To Treat? The Role of Immunotherapy in Non Small Cell Lung Cancer (NSCLC) With Oncogenic DriversLocation: Ballroom B-CCo-Speaker: – IU Health Simon Cancer Center
Co-Speaker: – Dana-Farber Cancer Institue
Mya Tran, PharmD, BCOP (she/her/hers) – IU Health Simon Cancer Center ### 1553102###Co-Speaker###Precision Oncology - Thoracic Clinical Pharmacist ###IU Health Simon Cancer Center###Co-Speaker: – IU Health Simon Cancer Center
### she/her/hers @@@ Leila Rostamnjad, PharmD, BCOP (she/her/hers) – Dana-Farber Cancer Institue ### 2127667###Co-Speaker###Clinical Pharmacy Manager-Solid Tumors. Thoracic Oncology and Symptoms Mangament Clinical Specialist###Dana-Farber Cancer Institue###Co-Speaker: – Dana-Farber Cancer Institue
### she/her/hers
9:25 AM – 10:25 AM ET
2 - Research Grant, Part 1: Oncology Pharmacist-Driven Symptom Monitoring System Uncovered Health Disparities in Minoritized Patients Receiving Anticancer Therapies
9:25 AM – 10:25 AM ET
403-A - Research Grant, Part 1: Oncology Pharmacist-Driven Symptom Monitoring System Uncovered Health Disparities in Minoritized Patients Receiving Anticancer TherapiesLocation: Ballroom ACo-Speaker: – School of Pharmacy & Pharmaceutical Sciences, University of California Irvine
Alexandre Chan, PharmD, MPH, FCCP, FISOPP, BCPS, BCOP, APh (he/him/his) – School of Pharmacy & Pharmaceutical Sciences, University of California Irvine ### 2226301###Co-Speaker###Founding Chair and Professor of Clinical Pharmacy###School of Pharmacy & Pharmaceutical Sciences, University of California Irvine###Co-Speaker: – School of Pharmacy & Pharmaceutical Sciences, University of California Irvine
### he/him/his
9:25 AM – 10:25 AM ET
3 - Research Grant, Part 2: Pharmacist Monitoring of Patient-Reported Outcome Measures (PROMs) for Oral Oncolytics
9:25 AM – 10:25 AM ET
403-B - Research Grant, Part 2: Pharmacist Monitoring of Patient-Reported Outcome Measures (PROMs) for Oral OncolyticsLocation: Ballroom ACo-Speaker: – University of North Carolina at Chapel Hill
Co-Speaker: – UNC Health
Angela M. Stover, PhD (she/her/hers) – University of North Carolina at Chapel Hill ### 2147184###Co-Speaker###Associate Professor###University of North Carolina at Chapel Hill###Co-Speaker: – University of North Carolina at Chapel Hill
### she/her/hers @@@ Debbie D. Liang, PharmD, BCCCP (she/her/hers) – UNC Health ### 2149106###Co-Speaker###Outcomes Research Pharmacist###UNC Health ###Co-Speaker: – UNC Health
### she/her/hers
9:25 AM – 10:25 AM ET
4 - Updates in Chronic Lymphocytic Leukemia: Sequencing Versus Combination Therapy of Small Molecule Inhibitors
9:25 AM – 10:25 AM ET
404 - Updates in Chronic Lymphocytic Leukemia: Sequencing Versus Combination Therapy of Small Molecule InhibitorsLocation: Ballroom DSpeaker: – Houston Methodist West Hospital
Clement T. Chung, PharmD, BCOP, BCPS, MS (he/him/his) – Houston Methodist West Hospital ### 2144500###Speaker###Senior clinical pharmacy specialist- Hematology/Oncology###Houston Methodist West Hospital###Speaker: – Houston Methodist West Hospital
### he/him/his
10:35 AM – 11:35 AM ET
Collaborative Practice in Clinical Trials: Reinforcements for the Crisis in Clinical Research
10:35 AM – 11:35 AM ET
406 - Collaborative Practice in Clinical Trials: Reinforcements for the Crisis in Clinical ResearchLocation: Ballroom ASpeaker: – Dana-Farber Cancer Institute
Jennifer Espiritu, PharmD, BCOP, CCRP – Dana-Farber Cancer Institute ### 929840###Speaker###Clinical Research Pharmacy Specialist###Dana-Farber Cancer Institute###Speaker: – Dana-Farber Cancer Institute
###
10:35 AM – 11:35 AM ET
Igniting Breakthroughs in Pharmacogenetics & Genomics: Unveiling the Pathogenic Potential of VUS Through DEI Enhancement
10:35 AM – 11:35 AM ET
405 - Igniting Breakthroughs in Pharmacogenetics & Genomics: Unveiling the Pathogenic Potential of VUS Through DEI EnhancementLocation: Ballroom B-CSpeaker: – PJW Clinical Pharmacy Consulting, LLC
Porscha Johnson, PharmD, CPGx (she/her/hers) – PJW Clinical Pharmacy Consulting, LLC ### 2127688###Speaker###Executive Owner/Principal Consultant, Medical Oncology/Pharmacogenomics###PJW Clinical Pharmacy Consulting, LLC###Speaker: – PJW Clinical Pharmacy Consulting, LLC
### she/her/hers
11:45 AM – 12:45 PM ET
Non-CE Symposium: Harnessing the Power of Human Immunity
11:45 AM – 12:45 PM ET
Non-CE Symposium: Harnessing the Power of Human ImmunityLocation: 122-123
Greg Eskinazi, RPh, BCOP, CCRP ### 2262387###*Speaker#########*Speaker:
### 11:45 AM – 12:45 PM ET
Non-CE Symposium: Long-Term Clinical Trial Results for a BTKi in the Treatment of CLL/SLLa
11:45 AM – 12:45 PM ET
Non-CE Symposium: Long-Term Clinical Trial Results for a BTKi in the Treatment of CLL/SLLaLocation: 120-121
Mark Wagner, PharmD ### 2251260###*Speaker#########*Speaker:
###
